
Charles Bradley Diagnosed with Cancerous Tumor and Cancels Tour, But Vows to Fight On
“I will fight through this like I’ve fought through the many other obstacles in my life.”
Oct 04, 2016
Charles Bradley
We are sad to report that modern soul legend Charles Bradley has been forced to cancel his tour because doctors have found a cancerous tumor in his stomach. The 67-year-old, who earlier this year released his third album, Changes, via Daptone and Dunham, has issued the below statement regarding his illness.
“My doctors recently discovered a cancerous tumor in my stomach.
“I’m getting the best medical care and we are all extremely optimistic. I will fight through this like I’ve fought through the many other obstacles in my life.
“My upcoming tour dates will be postponed so I can concentrate on healing.
“Thank you all for understanding. Music is how I share my love with the world, and the love that my fans have given back brings me so much joy. I look forward to seeing your gorgeous faces soon, and to continue to share my love through music.”
A press release points out that Bradley “has always been a fighter and is determined to come back stronger and with even more love to give.” Anyone who has seen him live can attest to how much energy he has for a man his age, so let’s all remain optimistic that Bradley will easily win this fight.
Below is the video for Changes track “Good to Be Back Home.” The black & white clip mixes footage of Bradley in and around his Bed-Stuy, Brooklyn home with shots of him performing.
Read our recent interview with Bradley about Changes.
Most Recent
- Sun June’s Laura Colwell on “Bad Dream Jaguar” and Navigating Change (Interview) — Sun June
- CMAT @ O2 Ritz, Manchester, UK, November 23, 2023 (Review) — CMAT
- Fillmore West, San Francisco, CA 3/2/1969 (Review) — Grateful Dead
- Under the Radar’s 2023 Holiday Gift Guide, Part 1: Tabletop Games (News) —
- 10 Best Songs of the Week: MGMT, Björk and Rosalía, Ducks Ltd., The Jesus and Mary Chain, and More (News) — Songs of the Week
Comments
Submit your comment
There are no comments for this entry yet.